“eleven-biotherapeutics” Archives

in
Entry Author Date Location
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Verdine Picks Backers For FogPharma’s $66M Round, Keeping Firm Control 05/16/18 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Eleven Biotherapeutics Receives $13,525,262 New Funding Round 09/29/16 Boston
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets 04/13/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Eleven Bio CFO Perry Heads to Aegerion 06/25/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
Eleven Bio’s Shares Routed as Dry Eye Drug Flunks Phase 3 Test 05/18/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Eleven Biotherapeutics Lands $20,000,010 New Financing Round 12/08/14 Boston
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray 11/18/14 Boston
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Eleven Prices IPO Below Projected Range, Grabs $50M 02/06/14 Boston
Page 1 of 2 next page »